Development of biocompatible antioxidant nanoparticles for xenobiotic-induced liver disease treatment by oral or parenteral administration is of great interest in medicine. In the current study, we demonstrate the protective effects of coenzyme Q10 nanoparticles (CoQ10-NPs) on hepatotoxicity induced by dichlorvos (DDVP) as an organophosphate. Although CoQ10 is an efficient antioxidant, its poor bioavailability has limited the applications of this useful agent. First, CoQ10-NPs were prepared then characterized using dynamic light scattering (DLS) and transmission electron microscopy (TEM). In DDVP-treated and non-treated hepatocytes in the presence of CoQ10-NPs, cell viability, the level of reactive oxygen species (ROS), lipid peroxidation (LPO), mitochondrial membrane potential (MMP), lysosome membrane integrity, and cellular glutathione (GSH) content were measured. The prepared CoQ10-NPs were mono-dispersed and had narrow size dis-
| I N TR ODU C TI ON
The exposure to organophosphates such as dichlorvos (DDVP) results in prominent neurotoxicity and hepatotoxicity.
1,2 Liver, with crucial importance in metabolism and detoxification of chemicals, seems to be a potential site for organophosphates especially DDVP-induced damages; 3, 4 however, it has been recognized that chronic and sub-chronic hepatotoxicity of organophosphates is closely linked to the oxidative stress. [5] [6] [7] DDVP is an organophosphate pesticide that effectively acts against various types of agricultural, household, public health and fish farming pests and works as plasticizers and flame retardants in industry. 8 Despite the regulations and/or limitations by the United States Environmental Protection Agency (EPA), World Health Organization (WHO) and Agency for Research on Cancer on human health risk, 9 it is still used over the world, particularly in developing countries, because of its broad-spectrum actions. Previous studies have demonstrated that in the mitochondria isolated from rat brain exposed to DDVP, GSH level decreases and content of ROS significantly increases. 1, 10 It has been recognized that powerful antioxidants such as Coenzyme Q10 (CoQ10), which can directly scavenge ROS and indirectly regenerate cellular vitamin E and C, are able to reduce the lipid Environmental Toxicology. 2017;1-11. wileyonlinelibrary.com/journal/tox peroxidation (LPO) in cellular membranes. 11 CoQ10, also known as ubiquinone, is a salient endogenous lipid-soluble and vitamin-like substance that acts as a proton-electron carrier in the mitochondrial electron transport chain and consequently supply energy need (ATP) of cell. 12, 13 Furthermore, it has been presented that CoQ10 had hepatoprotective impacts against xenobiotic-associated cellular damage and oxidative stress in several cases such as statins, acid salicylic acid, thioacetamide, tetrachloride carbon and doxorubicin. [14] [15] [16] In spite of having protective role against toxicities induced by xenobiotics, CoQ10 represents significant lipid solubility and low bioavailability that limit its clinical applications; therefore, higher doses are needed to be administered orally for clinical applications. 17 It is worth noting that researches have achieved obvious therapeutic effectiveness in humans only in the long term and high dose CoQ10 administration, which forces researchers to seek strategies for overcoming these limitations. 18 In this study, we aimed to test and compare the hepatoprotective and prophylactic effects of the nonparticulate CoQ10 on DDVPinduced hepatotoxicity and oxidative stress in isolated rat liver cells. In these cells, viability, ROS formation, lipid peroxidation, GSH level, and mitochondrial/lysosomal function were studied and for complementary investigations to confirm in vitro results we carried out in vivo assays that could valuate the DDVP-induced liver damage and effects of CoQ10 and CoQ10-NPs.
| M E TH ODS AN D M A TER I A LS

| Chemicals
Thiobarbituric acid (TBA), trypan blue, GSH, and phenobarbital were prepared from Merck Chemical Company (Darmstadt, Germany). 4-2-hydroxyethyl-1-piperazineethanesulfonic acid (HEPES were prepared from Acros (New Jersey, USA). Other agents were obtained from Sigma-Aldrich Chemical Company (St. Louis, MO).
| Synthesis of CoQ10-NPs
CoQ10 nanoparticles were produced by precipitation method. 18 The solvent for 10 mg of CoQ10 was ethanol (3.0 mL) which is the organic phase of the solution. The obtained solution was poured into 27.0 mL of double distilled water and stirred at 14,000 rpm for 15 s (Heidolph, silence crasher, Germany). After evaporation of ethanol by rotary vacuum at 408C water bath, a freeze dryer was used to lyophilize of remaining fraction. For the preparation of the coarse suspension, 30.0 mg of coenzyme Q10 was added in 30.0 mL of cold distilled water (containing 10% v/v ethanol). The coenzyme Q10 content of both was adjusted to about 1 mg/mL.
| Characterization of the prepared CoQ10-NPs
The particle size distribution and zeta potential of the CoQ10-NPs were determined by dynamic light scattering (DLS) using a nano/ zetasizer (Malvern Instruments, Worcestershire, UK, model Nano ZS) at room temperature. The synthesized nanoparticles were characterized for their size and structure by transmission electron microscopy (Zeiss, Germany). The samples stained with 0.5% (w/v) phosphotungstic acid on copper grids for observation before TEM analysis. 
| Animal treatment
| Isolation and incubation of rat hepatocytes
Rat hepatocytes were isolated with collagenase-perfusion method following the exclusion of calcium ions (Ca
21
) with a chelator (EGTA 0.5 mM) as described previously. 19 The isolated hepatocytes in a density of 10 6 /mL were then suspended in the Krebs-Henseleit buffer (pH 5 7.4) in continuously rotating round bottom flasks supplemented with 12.5mM HEPES, in a 378C water bath under an atmosphere of carbogen gas (95% O 2 and 5% CO 2 ). 20, 21 Hepatocytes were preincubated for 30 min prior to addition of chemicals to adopt the medium.
Freshly prepared chemical stock solutions (100 3 concentrated for the water solutions or 1000 3 concentrated for the methanolic solutions)
were utilized in this experiment. To avoid either nontoxic or very toxic circumstances, we used LC 50 concentrations (1mM) for DDVP.
| Cell viability
Hepatocyte viability was evaluated microscopically by trypan blue (0.1%, w/v) exclusion test [17] . Sampling was performed every 60 min during a 3h of incubation period while 85-90% of hepatocytes were viable before use
| Reactive oxygen species (ROS) formation assay
To assess the amount of hepatocyte ROS generation after DDVP was added to 2.7-dichlorofluorescein diacetate (DCFH-DA) containing hepatocytes to hepatocytes as it infiltrates hepatocytes and is hydrolyzed to non-fluorescent dichlorofluorescein (DCF) by an intracellular esterase. DCFH then reacts with reactive species and changes into highly fluorescent dichlorofluorescin. In 1, 2 and 3 h time points over isolation, 1 mL (10 6 cell) of hepatocytes suspension was picked up and centrifuged at 3000g for 1 min. Fluorescence intensity per 10 6 cells as a result of ROS production was measured using a Jasco R_FP-750 spectrofluorometric (Jasco Corporation, Tokyo, Japan) with excitation and emission wavelengths of 500 and 520 nm, respectively. 22 
| Determination of lipid peroxidation
Lipid peroxidation (LPO) of the hepatocytes was determined through measuring thiobarbituric acid reactive substances (TBARS). 23 Briefly, The cationic dye, rhodamine 123 accumulates in intact mitochondria.
When MMP is altered by any xenobiotic, the facilitated diffusion of dye is diminished leading to the elevation of the amount of rhodamine 123 in media. At the given times, aliquots of 1 mL samples of the cell suspension were taken and centrifuged at 1000 g for 1 min. Then, the cell pellet was resuspended in 2 mL of fresh incubation medium containing 1.5 lM of rhodamine 123 and incubated at 378C in a water bath with a gentle shaking. Hepatocytes were separated by centrifugation at 3000 g for 1 min and the amount of rhodamine 123 remaining in the incubation medium was calculated using a Jasco FP-750
fluorescence spectrophotometer set at 490 nm excitation and 520 nm emission wavelengths.
26,27
| Lysosomal membrane integrity assay
Acridine orange redistribution was utilized to assess the hepatocyte lysosomal membrane stability. 28 In brief, 0.5 mL of the prestained cell suspension with acridine orange (5 mM) was picked up from the incubation medium and was centrifuged 1 min at 800 g. Afterwards, the cell pellet was resuspended in 2 mL of fresh incubation buffer. In order to remove the florescent dye from the media, a two time washing process was performed. The distribution of dye in the cell suspension was then assessed fluorimetrically using a Jasco FP-750 fluorescence spectrophotometer set at 495 nm excitation and 530 nm emission wavelengths.
| Measurement of intracellular GSH and GSSG
Reduced glutathione (GSH) and glutathione disulfide (GSSG) in isolated hepatocytes was measured in deproteinized samples (5% metaphosphoric acid) after derivatization with iodoacetic acid and1-fluoro-2,4-dinitrobenzene, 29 using a mBondapak NH2 column, by HPLC (Water Associates, Milford, MA).
To do the experiment, the reaction of S-carboxymethyl derivatives of free thiols with iodoacetic acid was followed by conversion of free amino groups to 2, 4-dinitrophenyl derivatives through reaction with FDNB. Briefly, 0.8 mL of the cell suspension was spun at 50 g for 40 s, and the cell pellet was resuspended in 0.8 mL of fresh Krebs-Hensleit medium. Deproteinization of the cell suspension was performed with the addition of 0.2 mL volume of 25% metaphosphoric acid with a further centrifugation at 100g for 5 min. In the presence of excess sodium bicarbonate, the mixture of 0.5 mL of supernatant and 0.05 mL of iodoacetic acid was sealed and left in the dark and room temperature for 1 h. Eventually, 0.5 mL of FDNB solution (1.5%, v/v in ethanol) was added to the sample, left in the dark for 24 h at room temperature and then was examined by HPLC.
| In vivo studies
The animals were divided into following five groups (5 animals in each group) for 30 days: Group 1 (control): vehicle (0.9% saline solution) via oral gavage. Group 2: DDVP-treated animals (1.6 mg/kg body weight)
(1/50 LD oral dose) per day. Group 3: NAC (100 mg/kg body weight per day) 30 1 DDVP (1.6 mg/kg body weight per day) via oral gavage.
Group 4: CoQ10 (50 mg/kg body weight per day) 31 respectively. 32, 33 Total glutathione peroxidase (GPx) was measured as unit/mg protein according to the method of Flohe et al. 34 The protein concentration was asssed by the method of Lowry et al. 35 
| Statistical analysis
Data are presented as the Mean 6 SD for at three independent experiments. Results were statistically analyzed by one-way analysis of variance (ANOVA) followed by Tukey's post hoc test to assess significance. Results with values for P < .05 were taken as statistically significant.
| RE S U L TS
| Particle size analysis and morphological characterization
As shown in DLS plot, it is evident that prepared NPs have a narrow size distribution and are highly monodispersed ( Figure 1A) . Moreover, the CoQ10-NPs displayed an effective diameter of 54 nm, while zeta potential was found to be 224 mV ( Figure 1A) . Additionally, TEM micrograph shows that CoQ10-NPs are morphologically spherical and uniform in size distributions, which was confirmed the results of DLS analysis ( Figure 1B ). As presented in Figure 2 , the appearances of coarse suspensions and the CoQ10-NPs were different. It was found that all nanocrystals were homodispersed; on the contrary, the bulk CoQ10 dispersed in suspension was quite unstable after 2 days, while the 54 nm-sized nanocrystals were physically stable for during 3 month at room temperature.
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| The effects of DDVP on GSH/GSSG levels
Incubation of hepatocytes with DDVP (1mM) potentiate glutathione depletion of GSH which was significantly prevented by CoQ10 and NAC (P < .05) ( Table 1) .Interestingly, administration of CoQ10-NPs reduces the glutathione reduction profoundly more than free CoQ10 in isolated hepatocytes (Table 1 ). All these findings indicate the occurrence of oxidative stress after DDVP administration in isolated rat. 
| In vivo results
ALT, AST and GGT as main markers of liver function in different treated groups are presented in Table 2 . DDVP administration increased the levels of AST, ALT, and GGT to higher extend when compare to the control group (P < .05). In contrast pretreatment of rats with NAC, CoQ10 and CoQ10-NPs significantly reduced the above-mentioned alterations (P < .05). Moreover, AST, ALT and GGT levels were significantly lower in of CoQ10-NPs (P < .05) ( Table 2 ). The histopathological results showed that DDVP administration causes hepatocyte degeneration, fatty changes and inflammatory cell infiltration which was significantly improved after CoQ10 and also CoQ10-NPs. However, this effect was in a greater extent in CoQ10-NP treated group ( Figure 8 ).
As shown in Table 3 , DDVP-intoxication significantly plummeted the activity of the SOD, CAT, and GPx enzymes compared with the normal control (P < .05). While, pretreatment of rats with NAC, CoQ10 and CoQ10-NPs significantly improved liver antioxidant content (P < .05).
Also, the result of this study showed that particulated CoQ10 had a more beneficial effect in antioxidant activity of DDVP-intoxicated livers.
| D ISC USSION
Nano antioxidants like CoQ10 nanoparticles are safe, biocompatible, and biodegradable with no toxicity and possessing intrinsic antioxidant properties in attenuating of free radical induced oxidative damage. . In this study, we used the nanoprecipitation technique that possesses numerous benefits, which offers reproducible particle size with a narrow distribution (PDI value of 0.18) and is comparatively straightforward and rapid.
Preparing reproducible particle size and being a rapid technique makes nanoprecipitation a favorite method to produce nanomaterials and we also used in this experiment. [37] [38] [39] The smaller nanoparticles are made, the larger surface area is provided leading to enhanced efficacy and increased agent bioavailability. Besides, it appears that original physicochemical properties are boosted with nanoparticulation, providing the crystalline structure which might alter the release profile of nonparticulate CoQ10.
The intensity-weighted mean diameter of the bulk population
is measured with DLS method or photon correlation spectroscopy (PCS). As presented in Figure 1A , the diameter for CoQ10-NPs was calculated to be 54 and the prepared CoQ10-NPs had a narrow size distribution with a spherical and uniform morphology ( Figure 1B) . DDVP administration has been shown to induce oxidative stress which is concomitant with decreased glutathione reductase, reduced and oxidized glutathione levels in different tissues. 2 In the current study, we observed a substantial GSH deprivation, which might be a mechanism for the DDVP-induced toxicity in isolated rat hepatocytes.
Our results showed that antioxidants (NAC and CoQ10) are able to increase hepatocytes glutathione levels and this effect may also contribute to protection against DDVP-induced cytotoxicity. Also, for the first time, this study demonstrated that potential antioxidant effect of nano-CoQ10 was considerably higher than CoQ10 in replenishment of GSH pools in DDVP-exposed isolated rat hepatocytes. Our in vivo studies showed that DDVP induced hepatotoxicity in rats, which were associated by the increment of liver function enzymes and decrease in the activity of antioxidant enzymes.
Regarding our in vivo work, DDVP has a significant effect in mitigation of liver antioxidant enzyme levels.
H 2 O 2 is produced via the function of SOD followed by induction of hydroxyl radicals throughout Fenton and/or Haber-Weiss reactions if the agent is not removed by CAT and/or GSH. 44 Exposure to organophosphate pesticides is often followed by impairment of the antioxidant defense and characterized by the depletion of GSH. In the current study, we showed that NAC, CoQ10 and its nanoparticles counterpart played detoxifying roles in metabolizing the xenobiotics through enhancement of SOD, CAT, and GPx levels to scavenge the ROS radicals and MDA levels generated from DDVP. Furthermore, our data also proposed that pretreatment with NAC, CoQ10 and CoQ10-NPs effectively reduced the leakage of AST, ALT and GGT and prevented the DDVP-intoxication-mediated progression of hepatotoxicity which were also apparent in the histopathological results. The effects of CoQ10-NPs in DDVP-induced liver toxicity were summarized in Figure 9 .
| CON CL U S I ON
The outcomes of this study revealed the hepatoprotective role of CoQ10-NPs as well as its enhanced antioxidant effect to improve In summary, CoQ-NPs are deemed to be a safe supplementary therapeutics in pathologies related to xenobiotics-induced liver injuries.
